Drugs Information:
Asenapine
Basic Information
|
||
ID | DDInter125 | |
Drug Type | small molecule | |
Molecular Formula | C17H16ClNO | |
Molecular Weight | 285.770 | |
CAS Number | 65576-45-6 | |
Description | Developed by Schering-Plough after its merger with Organon International, asenapine is a sublingually administered, atypical antipsychotic for treatment of schizophrenia and acute mania associated with bipolar disorder. Asenapine also belongs to the dibenzo-oxepino pyrrole class. It is also for severe post-traumatic stress disorder nightmares in soldiers as an off-label use. FDA approved on August 13, 2009. | |
ATC Classification | N05AH05 | |
IUPAC Name | 9-chloro-4-methyl-13-oxa-4-azatetracyclo[12.4.0.0^{2,6}.0^{7,12}]octadeca-1(14),7,9,11,15,17-hexaene | |
InChI | VSWBSWWIRNCQIJ-UHFFFAOYSA-N | |
Canonical SMILES | CN1CC2C(C1)C1=C(OC3=CC=C(Cl)C=C23)C=CC=C1 | |
Useful Links | DrugBank ChEBI PubChem Substance KEGG Drug ChemSpider Wikipedia ChEMBL ZINC |
Interactions with
Asenapine
Filter:
Severity level | ID | Name | Mechanism | Detail |
---|
Interactions with diseases
Filter:
Severity level | Disease name | Text | References |
---|
Interactions with foods
Filter:
Severity level | Food name | Description | Management | Mechanism | References |
---|
Interactions with compound preparation
Multi-DRUG trade | Multi-DRUG | Drug type | Warning | Note |
---|